SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 94 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,547,770 | -43.6% | 409,463 | 0.0% | 0.22% | -46.0% |
| Q2 2023 | $2,743,402 | +2.9% | 409,463 | 0.0% | 0.40% | +1.8% |
| Q1 2023 | $2,665,604 | -23.7% | 409,463 | 0.0% | 0.40% | -21.7% |
| Q4 2022 | $3,492,719 | +61.6% | 409,463 | 0.0% | 0.51% | +91.3% |
| Q3 2022 | $2,162,000 | – | 409,463 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
| Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
| EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
| Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
| 5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
| COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
| RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
| HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
| Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |